BCMIO
PVCT

Beacon Capital Management Inc (Ohio)’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio PVCT Stock Details PVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-400
Closed – – 232
2014
Q3 		$0 Hold
400
– – ﹤0.01% 228
2014
Q2 		$0 Buy
+400
New +$479 ﹤0.01% 300

Other funds holding PVCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s PVCT Position: Q4 2014 in Review

Beacon Capital Management Inc (Ohio) sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2014, closing a stake of 400 shares.

Beacon Capital Management Inc (Ohio) first reported a position in PVCT in Q2 2014 and held it in 2 quarters. The position peaked at $0 in Q3 2014. 39 funds tracked by Wall St. Rank hold PVCT as of Q4 2014.

  • Beacon Capital Management Inc (Ohio) reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2014 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 400 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2014.
  • Beacon Capital Management Inc (Ohio) first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 2 quarters.
  • Beacon Capital Management Inc (Ohio)'s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $0 in Q3 2014.
  • 39 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2014.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q4 2014, filed 13 Jan 2015.